Abstract
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Multiple Sclerosis, Date of authorisation: 17/03/2011, Revision: 23, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have